NEWS

Nov 17,2021

Announcement on Soliciting Public Opinions on the Measures for the Administration of the National Essential Drug List (Revised Draft)

In order to further consolidate the national essential drug system and establish and improve the selection and adjustment mechanism of the national essential drug list, the Department of Drug Administration of the National Health Commission organized the study and revision of the measures for the Administration of the National essential Drug list (issued in 2015), and formed the revised draft of the measures for the Administration of the National essential Drug list (see annex). Now for the public to solicit opinions.

Key words:

Announcement on Soliciting Public Opinions on the Measures for the Administration of the National Essential Drug List (Revised Draft)

Nov 17,2021

Product Specialist

Key words:

Product Specialist

Nov 17,2021

Provincial Manager

Key words:

Provincial Manager

Nov 17,2021

Quality Inspection (QC)

Key words:

Quality Inspection (QC)

Nov 17,2021

Quality Management (QA)

Key words:

Quality Management (QA)

Nov 17,2021

Pharmaceutical Formulation Researcher

Key words:

Pharmaceutical Formulation Researcher
< 1...141142143...162 >
Chenglian Medicine

Follow us

Zhejiang Jianfeng Pharmaceutical Co., Ltd.

Sales Line:

+86-579-82131973
Mailbox:gs@zjifyy.com.cn
Company address: No.88, Wujiang East Road, Jinhua City, Zhejiang Province

Copyright©2023 Zhejiang Jianfeng Pharmaceutical Co., Ltd

Powered by www.300.cn | SEO  | Business License

SAF Coolest v1.3.1.1 设置面板XRBSX-ZEJN-JAAZE-ZWD

图片ALT信息： JIANFENG

无数据提示

Sorry, the current column is being updated, please look forward to it!

You can view other columns or returnHome Page